| 6001 | IL1RL1 levels | GCST90469574 | 0.13 |
| 6002 | SIGLEC7 levels | GCST90470635 | 0.13 |
| 6003 | Vanillactate levels | GCST90199978 | 0.13 |
| 6004 | CD58 levels | GCST90468638 | 0.13 |
| 6005 | PZP levels | GCST90470399 | 0.13 |
| 6006 | COX5B/METAP1D ratio | GCST90314201 | 0.13 |
| 6007 | OLR1/PLAUR ratio | GCST90315584 | 0.13 |
| 6008 | Estimated glomerular filtration rate, serum creatinine + cystain C | Other measurement | UKBB00000211 | 0.13 |
| 6009 | Phospholipids to total lipids in large VLDL percentage (UKB data field 23589) | GCST90269686 | 0.13 |
| 6010 | ICD10 N87: Dysplasia of cervix uteri | GCST90454218 | 0.13 |
| 6011 | IL1R2 levels | GCST90469572 | 0.13 |
| 6012 | Volume of left lateral nucleus | GCST90474889 | 0.13 |
| 6013 | 1-palmitoyl-2-stearoyl-gpc (16:0/18:0) levels | GCST90200041 | 0.13 |
| 6014 | Cancer of kidney and renal pelvis (PheCode 189.1) | GCST90475595 | 0.13 |
| 6015 | RBM17 levels | GCST90470434 | 0.13 |
| 6016 | PDGFB/SNAP29 ratio | GCST90315627 | 0.13 |
| 6017 | IDP T1 FAST ROIs R thalamus | GCST90002548 | 0.13 |
| 6018 | Volume of right paralaminar nucleus | GCST90474928 | 0.13 |
| 6019 | Asparagine levels | GCST90243758 | 0.13 |
| 6020 | Nontoxic uninodular goiter (PheCode 241.1) | GCST90475640 | 0.13 |
| 6021 | Carcinoma in situ of breast, intraductal (controls excluding all cancers) | FING00000240 | 0.13 |
| 6022 | TNFAIP8L2 levels | GCST90470897 | 0.13 |
| 6023 | BCR levels | GCST90468436 | 0.13 |
| 6024 | LDLRAP1 levels | GCST90469749 | 0.13 |
| 6025 | DTI autoptx MD ilf r tract | GCST90385235 | 0.12 |
| 6026 | REG3A levels | GCST90470449 | 0.12 |
| 6027 | IDP dMRI TBSS FA Posterior thalamic radiation R | GCST90003905 | 0.12 |
| 6028 | ACAA1 levels | GCST90468193 | 0.12 |
| 6029 | LAIR2 levels | GCST90469729 | 0.12 |
| 6030 | Corns and callosities (PheCode 700) | GCST90476196 | 0.12 |
| 6031 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T59 | ECGU000059 | 0.12 |
| 6032 | YES1 levels | GCST90471088 | 0.12 |
| 6033 | PLAUR/TREM2 ratio | GCST90315676 | 0.12 |
| 6034 | Concentration of large HDL particles | GCST90092851 | 0.12 |
| 6035 | aparc-a2009s rh volume S-intrapariet+P-trans | GCST90003054 | 0.12 |
| 6036 | EDAR levels | GCST90469068 | 0.12 |
| 6037 | FCRLB levels | GCST90469210 | 0.12 |
| 6038 | GIMAP7 levels | GCST90469345 | 0.12 |
| 6039 | ATOX1/SPARC ratio | GCST90313375 | 0.12 |
| 6040 | IFIH1 levels | GCST90423689 | 0.12 |
| 6041 | T1 FreeSurfer a2009s lh G precentral volume | GCST90384844 | 0.12 |
| 6042 | KLK1 levels | GCST90469702 | 0.12 |
| 6043 | CD99 levels | GCST90468658 | 0.12 |
| 6044 | Treatment/medication code - amlodipine | Medications | UKBB00000840 | 0.12 |
| 6045 | Benign paroxysmal vertigo | FING00000210 | 0.12 |
| 6046 | ARL13B levels | GCST90468363 | 0.12 |
| 6047 | triglyceride (maximum, inv-norm transformed) | GCST90476431 | 0.12 |
| 6048 | REST UKBBICA NODEamps25 0014 | GCST90385497 | 0.12 |
| 6049 | IDP dMRI TBSS MD Anterior limb of internal capsule L | GCST90004044 | 0.12 |
| 6050 | CCL16 levels | GCST90468568 | 0.12 |
| 6051 | IDS/SMPDL3A ratio | GCST90315126 | 0.12 |
| 6052 | DAB2 levels | GCST90468942 | 0.12 |
| 6053 | 1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) metabolite level | GCST90616405 | 0.12 |
| 6054 | GOPC levels | GCST90469377 | 0.12 |
| 6055 | S100G levels | GCST90470519 | 0.12 |
| 6056 | DTI TBSS L3 Superior corona radiata L | GCST90384549 | 0.12 |
| 6057 | Spondylosis | FING00001327 | 0.12 |
| 6058 | PCDH9 levels | GCST90470172 | 0.12 |
| 6059 | CASP3 levels | GCST90468545 | 0.12 |
| 6060 | Phospholipids to total lipids in very large VLDL percentage (UKB data field 23584) | GCST90269681 | 0.12 |
| 6061 | DNMBP levels | GCST90469023 | 0.12 |
| 6062 | SMAD1 levels | GCST90470675 | 0.12 |
| 6063 | CCL7 levels | GCST90468585 | 0.12 |
| 6064 | REST UKBBICA NET100 1212 | GCST90387066 | 0.12 |
| 6065 | T1 CAT volume R InsularCortex | GCST90384003 | 0.12 |
| 6066 | Operation code - squint correction | Operations | UKBB00000566 | 0.12 |
| 6067 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T93 | ECGU000093 | 0.12 |
| 6068 | Comorbidity of gastric and duodenal ulcers | GCST90270929 | 0.12 |
| 6069 | IDP dMRI ProbtrackX FA ptr l | GCST90003944 | 0.12 |
| 6070 | LTBR levels | GCST90469816 | 0.12 |
| 6071 | IRAK1/SPRY2 ratio | GCST90315196 | 0.12 |
| 6072 | DTI autoptx L2 unc r tract | GCST90385192 | 0.12 |
| 6073 | Heart rate variability (standard deviation of normal-to-normal intervals) | GCST90281265 | 0.12 |
| 6074 | Omega-3 fatty acid levels | GCST90502423 | 0.12 |
| 6075 | COLEC12/TNFRSF1A ratio | GCST90314187 | 0.12 |
| 6076 | Hydrocele | FING00000627 | 0.12 |
| 6077 | LIFR levels | GCST90469769 | 0.12 |
| 6078 | Calculus of kidney (PheCode 594.1) | GCST90476145 | 0.12 |
| 6079 | DDR1 levels | GCST90468970 | 0.12 |
| 6080 | Mood swings | Mental health | UKBB00000482 | 0.12 |
| 6081 | CD46 levels | GCST90468634 | 0.12 |
| 6082 | SERPINA11 levels | GCST90470580 | 0.12 |
| 6083 | wg rh intensity-contrast middletemporal | GCST90003841 | 0.12 |
| 6084 | HHEX levels | GCST90469451 | 0.12 |
| 6085 | Total lipid levels in large HDL | GCST90092850 | 0.12 |
| 6086 | TWF2 levels | GCST90470987 | 0.12 |
| 6087 | Left-hemisphere visual network to right-hemisphere default mode network white-matter structural connectivity | GCST90302661 | 0.12 |
| 6088 | triglyceride (mean, inv-norm transformed) | GCST90476435 | 0.12 |
| 6089 | TRIM25 levels | GCST90470966 | 0.12 |
| 6090 | CTSF levels | GCST90468912 | 0.12 |
| 6091 | CST3 levels | GCST90468894 | 0.12 |
| 6092 | BLVRB/HMBS ratio | GCST90313526 | 0.12 |
| 6093 | Type 2 diabetes, wide definition | FING00001383 | 0.12 |
| 6094 | IDP T1 SIENAX grey normalised volume | GCST90002430 | 0.12 |
| 6095 | Estimated glomerular filtration rate (creatinine) | GCST90428447 | 0.12 |
| 6096 | TNFRSF11A levels | GCST90277644 | 0.12 |
| 6097 | SHBG levels | GCST90470622 | 0.12 |
| 6098 | AmygNuclei lh volume Accessory-Basal-nucleus | GCST90002650 | 0.12 |
| 6099 | CD300LG levels | GCST90468623 | 0.12 |
| 6100 | Chronic Kidney Disease, Stage III (PheCode 585.33) | GCST90476128 | 0.12 |
| 6101 | IDP T1 FAST ROIs L thalamus | GCST90002547 | 0.12 |
| 6102 | Abscess of anal and rectal regions | FING00000005 | 0.12 |
| 6103 | SYT1 levels | GCST90470794 | 0.11 |
| 6104 | Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2) | GCST90044025 | 0.11 |
| 6105 | Father's age | Family history | UKBB00000240 | 0.11 |
| 6106 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T485 | ECGA000485 | 0.11 |
| 6107 | Pollen allergy | FING00001176 | 0.11 |
| 6108 | FKBP1B/PRDX5 ratio | GCST90314833 | 0.11 |
| 6109 | GFER/MAVS ratio | GCST90314919 | 0.11 |
| 6110 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T96 | ECGU000096 | 0.11 |
| 6111 | BCR/PLXNA4 ratio | GCST90313497 | 0.11 |
| 6112 | Methods of admission to hospital (recoded) - Elective admission: Waiting List | Summary Administration | UKBB00000463 | 0.11 |
| 6113 | Cerebral ischemia (PheCode 433.3) | GCST90475988 | 0.11 |
| 6114 | triglyceride (minimum, inv-norm transformed) | GCST90476439 | 0.11 |
| 6115 | IL1RN levels | GCST90012004 | 0.11 |
| 6116 | MGLL/PTPN6 ratio | GCST90315440 | 0.11 |
| 6117 | wg rh intensity-contrast fusiform | GCST90003833 | 0.11 |
| 6118 | TNFRSF14/TNFRSF1A ratio | GCST90315935 | 0.11 |
| 6119 | APRT/CD63 ratio | GCST90313334 | 0.11 |
| 6120 | AMBP/HAVCR1 ratio | GCST90313254 | 0.11 |
| 6121 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T72 | ECGU000072 | 0.11 |
| 6122 | PDGF-BB levels | GCST90428430 | 0.11 |
| 6123 | MANF/PRDX5 ratio | GCST90315365 | 0.11 |
| 6124 | NQO2 levels | GCST90242679 | 0.11 |
| 6125 | CKAP4/PGF ratio | GCST90314075 | 0.11 |
| 6126 | Left ventricular mass (indexed to body surface area) | GCST90435260 | 0.11 |
| 6127 | Blood cell traits latent factor 9 (white cell) | GCST90559251 | 0.11 |
| 6128 | GALNT10 levels | GCST90469295 | 0.11 |
| 6129 | Operation code - spinal laminectomy | Operations | UKBB00000564 | 0.11 |
| 6130 | 1-stearoyl-2-arachidonoyl-GPC (18:0/20:4) metabolite level | GCST90615670 | 0.11 |
| 6131 | Qualifications - Other professional qualifications eg: nursing, teaching | Education | UKBB00000732 | 0.11 |
| 6132 | CACYBP levels | GCST90468524 | 0.11 |
| 6133 | Placental weight (paternal genotype, adjusted for sex) | GCST90275199 | 0.11 |
| 6134 | Grapefruit liking | GCST90094774 | 0.11 |
| 6135 | Medication use (immunosuppressants) | GCST90018771 | 0.11 |
| 6136 | Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers) | FING00000864 | 0.11 |
| 6137 | IDP SWI T2star left putamen | GCST90003867 | 0.11 |
| 6138 | MANF/PDGFB ratio | GCST90315360 | 0.11 |
| 6139 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502388 | 0.11 |
| 6140 | Urinary calculus (PheCode 594) | GCST90476143 | 0.11 |
| 6141 | PODXL2 levels | GCST90470279 | 0.11 |
| 6142 | Subarachnoid hemorrhage | GCST90018703 | 0.11 |
| 6143 | Chronic bronchitis | respiratory | UKBB00000136 | 0.11 |
| 6144 | ANPEP/DPP4 ratio | GCST90313273 | 0.11 |
| 6145 | DPP6 levels | GCST90469034 | 0.11 |
| 6146 | MUC16 levels | GCST90469964 | 0.11 |
| 6147 | WASHC3 levels | GCST90471069 | 0.11 |
| 6148 | Idiopathic pulmonary fibrosis | FING00000659 | 0.11 |
| 6149 | FAM172A levels | GCST90469184 | 0.11 |
| 6150 | Atherosclerosis, excluding cerebral and coronary sclerosis | FING00000123 | 0.11 |
| 6151 | TARBP2 levels | GCST90470805 | 0.11 |
| 6152 | CX3CL1/RGMB ratio | GCST90314327 | 0.11 |
| 6153 | DSG2 levels | GCST90427825 | 0.11 |
| 6154 | Vitamin and mineral supplements - None of the above | Medication | UKBB00000901 | 0.11 |
| 6155 | Congenital malformations of heart and great arteries | FING00000336 | 0.11 |
| 6156 | COMP/DPP4 ratio | GCST90314188 | 0.11 |
| 6157 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T495 | ECGU000495 | 0.11 |
| 6158 | BCAN/KLK6 ratio | GCST90313479 | 0.11 |
| 6159 | high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed) | GCST90475356 | 0.11 |
| 6160 | LSP1/NADK ratio | GCST90315331 | 0.11 |
| 6161 | IL34 levels | GCST90469593 | 0.11 |
| 6162 | LDLR levels | GCST90179346 | 0.11 |
| 6163 | NAGK levels | GCST90469995 | 0.11 |
| 6164 | IDP dMRI ProbtrackX L1 ifo l | GCST90004258 | 0.11 |
| 6165 | TBCA levels | GCST90470812 | 0.11 |
| 6166 | aseg lh intensity Accumbens-area | GCST90003774 | 0.11 |
| 6167 | TXLNA levels | GCST90470989 | 0.11 |
| 6168 | LAT2/YES1 ratio | GCST90315282 | 0.11 |
| 6169 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T233 | ECGU000233 | 0.11 |
| 6170 | DTI autoptx FA ifo l tract | GCST90385124 | 0.11 |
| 6171 | Total Sphingomyelin levels | GCST90025842 | 0.11 |
| 6172 | SNAP23/TBL1X ratio | GCST90315856 | 0.11 |
| 6173 | BA-exvivo rh area BA2 | GCST90003222 | 0.11 |
| 6174 | Left-hemisphere limbic network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302732 | 0.11 |
| 6175 | NID1/SORT1 ratio | GCST90315542 | 0.10 |
| 6176 | Fasting blood glucose | GCST005186 | 0.10 |
| 6177 | EIF4G1/FOXO1 ratio | GCST90314634 | 0.10 |
| 6178 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T105 | ECGU000105 | 0.10 |
| 6179 | DSC2/SPINT1 ratio | GCST90314557 | 0.10 |
| 6180 | aseg lh volume Hippocampus | GCST90002624 | 0.10 |
| 6181 | NUCB2 levels | GCST90470101 | 0.10 |
| 6182 | Recent feelings or nervousness or anxiety | Anxiety | UKBB00000741 | 0.10 |
| 6183 | DTI TBSS L1 Posterior thalamic radiation L | GCST90384457 | 0.10 |
| 6184 | Blood cell traits latent factor 1 (white cell) | GCST90559243 | 0.10 |
| 6185 | T1 FreeSurfer aseg Right-Pallidum | GCST90384164 | 0.10 |
| 6186 | Medication use (drugs affecting bone structure and mineralization) | GCST90018773 | 0.10 |
| 6187 | Interpolated Year when non-cancer illness first diagnosed | Medical conditions | UKBB00000371 | 0.10 |
| 6188 | TPPP3 levels | GCST90470948 | 0.10 |
| 6189 | Late-onset myasthenia gravis | GCST90093466 | 0.10 |
| 6190 | MANF/SNX9 ratio | GCST90315368 | 0.10 |
| 6191 | Right ventricular ejection fraction | GCST90268117 | 0.10 |
| 6192 | VSTM1 levels | GCST90471055 | 0.10 |
| 6193 | PIKFYVE levels | GCST90470235 | 0.10 |
| 6194 | Creatinine levels | GCST90497237 | 0.10 |
| 6195 | Depression | Mental distress | UKBB00000165 | 0.10 |
| 6196 | Bioavailable testosterone levels | GCST90012102 | 0.10 |
| 6197 | EXTL1 levels | GCST90469161 | 0.10 |
| 6198 | CCL14/CST3 ratio | GCST90313679 | 0.10 |
| 6199 | Phosphatidylcholine diacyl C38:3 levels | GCST90240045 | 0.10 |
| 6200 | Constipation | FING00000348 | 0.10 |
| 6201 | Triacylglycerol_45:4_[M+NH4]1+ levels | GCST90060333 | 0.10 |
| 6202 | NBL1 levels | GCST90470001 | 0.10 |
| 6203 | IDP dMRI TBSS MD Genu of corpus callosum | GCST90004029 | 0.10 |
| 6204 | DTI autoptx L2 fmi tract | GCST90385177 | 0.10 |
| 6205 | T1 FreeSurfer pial rh posteriorcingulate area | GCST90385844 | 0.10 |
| 6206 | rfMRI connectivity (ICA25 edge 103) | GCST90004746 | 0.10 |
| 6207 | BCR/ITGB1BP2 ratio | GCST90313494 | 0.10 |
| 6208 | PRKAB1 levels | GCST90470324 | 0.10 |
| 6209 | CCDC80 levels | GCST90468562 | 0.10 |
| 6210 | ENO2/PLXNA4 ratio | GCST90314665 | 0.10 |
| 6211 | Weight | Impedance measures | UKBB00000910 | 0.10 |
| 6212 | Allergic rhinitis | FING00000071 | 0.10 |
| 6213 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T45 | ECGA000045 | 0.10 |
| 6214 | DTI TBSS FA Anterior corona radiata L | GCST90384403 | 0.10 |
| 6215 | AXIN1/MAVS ratio | GCST90313414 | 0.10 |
| 6216 | Seen doctor (GP) for nerves, anxiety, tension or depression | Mental health | UKBB00000765 | 0.10 |
| 6217 | Heart failure with reduced EF [Systolic or combined heart failure] (PheCode 428.3) | GCST90475983 | 0.10 |
| 6218 | CALCOCO1/MAP3K5 ratio | GCST90313605 | 0.10 |
| 6219 | Hemoglobin A1c (HbA1c, minimum, inv-norm transformed) | GCST90475097 | 0.10 |
| 6220 | Principal component-derived dietary pattern 26 | GCST90133031 | 0.10 |
| 6221 | T1 FreeSurfer DK rh MeanThickness thickness | GCST90385757 | 0.10 |
| 6222 | Triacylglycerol_53:2_[M+NH4]1+ levels | GCST90060531 | 0.10 |
| 6223 | GZMA/TNFRSF8 ratio | GCST90315014 | 0.10 |
| 6224 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T429 | ECGU000429 | 0.10 |
| 6225 | Nonischemic cardiomyopathy | FING00000883 | 0.10 |
| 6226 | CDKN1A/NCK2 ratio | GCST90313973 | 0.10 |
| 6227 | DAB2/TBL1X ratio | GCST90314368 | 0.10 |
| 6228 | aparc-a2009s rh volume G-front-inf-Triangul | GCST90003012 | 0.10 |
| 6229 | Lymphocyte count | GCST90018742 | 0.10 |
| 6230 | Docosahexaenoic acid levels | GCST90502258 | 0.10 |
| 6231 | SERPINA4 levels | GCST90470584 | 0.10 |
| 6232 | IDP dMRI TBSS FA Superior fronto-occipital fasciculus R | GCST90003919 | 0.10 |
| 6233 | CABP2 levels | GCST90468519 | 0.10 |
| 6234 | DTI TBSS L3 Anterior corona radiata L | GCST90384547 | 0.10 |
| 6235 | LONP1 levels | GCST90469785 | 0.10 |
| 6236 | IDP dMRI TBSS ICVF Cingulum cingulate gyrus R | GCST90004361 | 0.10 |
| 6237 | GHR levels | GCST90469342 | 0.10 |
| 6238 | Hip circumference | Body size measures | UKBB00000328 | 0.10 |
| 6239 | CALCOCO2 levels | GCST90468531 | 0.10 |
| 6240 | NBN levels | GCST90470002 | 0.10 |
| 6241 | ADAM22 levels | GCST90468218 | 0.10 |
| 6242 | Physical activity (Total log acceleration 6am-8am) | GCST90061412 | 0.10 |
| 6243 | Other circulatory problem | GCST90475217 | 0.10 |
| 6244 | Subarachnoid haemorrhage | FING00001339 | 0.10 |
| 6245 | Straight vs curly hair | GCST006094 | 0.10 |
| 6246 | Other extrapyramidal and movement disorders in other diseases | FING00001047 | 0.10 |
| 6247 | IDP T1 FAST ROIs L pallidum | GCST90002553 | 0.10 |
| 6248 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T469 | ECGA000469 | 0.10 |
| 6249 | wg rh intensity-contrast cuneus | GCST90003831 | 0.10 |
| 6250 | GZMA/GZMH ratio | GCST90315008 | 0.10 |
| 6251 | CNDP1/EGFR ratio | GCST90314146 | 0.10 |
| 6252 | ERBB3 levels | GCST90469140 | 0.10 |
| 6253 | CCL18/RARRES2 ratio | GCST90313690 | 0.10 |
| 6254 | XCL1 levels | GCST90471081 | 0.10 |
| 6255 | NCF2 levels | GCST90470006 | 0.10 |
| 6256 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T106 | ECGU000106 | 0.10 |
| 6257 | GZMA/IL12A_IL12B ratio | GCST90315009 | 0.10 |
| 6258 | Sources of admission to hospital (recoded) - Usual Place of residence | Summary Administration | UKBB00000786 | 0.09 |
| 6259 | aparc-a2009s lh volume S-circular-insula-sup | GCST90002973 | 0.09 |
| 6260 | Asthma (adult onset) | GCST007799 | 0.09 |
| 6261 | RPE levels | GCST90470495 | 0.09 |
| 6262 | Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levels | GCST90060326 | 0.09 |
| 6263 | estimated glomerular filtration rate (eGFR, minimum, inv-norm transformed) | GCST90475285 | 0.09 |
| 6264 | ABL1 levels | GCST90468190 | 0.09 |
| 6265 | LSIL lesion of the cervix uteri | FING00000732 | 0.09 |
| 6266 | SIRPA levels | GCST90470639 | 0.09 |
| 6267 | Amyotrophic lateral sclerosis | GCST90027164 | 0.09 |
| 6268 | IRAG2 levels | GCST90469626 | 0.09 |
| 6269 | Back pain | symptoms | UKBB00000084 | 0.09 |
| 6270 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T58 | ECGA000058 | 0.09 |
| 6271 | Heart rate variability (corrected root mean square of successive differences) | GCST90281264 | 0.09 |
| 6272 | mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed) | GCST90475460 | 0.09 |
| 6273 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 13) | GCST90320576 | 0.09 |
| 6274 | Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 8.07_212.10) | GCST90291805 | 0.09 |
| 6275 | Beetroot liking | GCST90094702 | 0.09 |
| 6276 | CRADD/FADD ratio | GCST90314237 | 0.09 |
| 6277 | RAD23B levels | GCST90470418 | 0.09 |
| 6278 | Lysophosphatidylcholine (20:3) [sn1] levels | GCST90024169 | 0.09 |
| 6279 | IDP dMRI ProbtrackX ISOVF ifo r | GCST90004538 | 0.09 |
| 6280 | aparc-a2009s lh area S-precentral-sup-part | GCST90003365 | 0.09 |
| 6281 | METAP1D/PLXNA4 ratio | GCST90315427 | 0.09 |
| 6282 | Colonic or urogenital fistula | FING00000315 | 0.09 |
| 6283 | CD248 levels | GCST90468612 | 0.09 |
| 6284 | AMOT levels | GCST90468295 | 0.09 |
| 6285 | GATD3 levels | GCST90469309 | 0.09 |
| 6286 | COX5B/GFER ratio | GCST90314200 | 0.09 |
| 6287 | red blood cell count (RBC, mean, inv-norm transformed) | GCST90476349 | 0.09 |
| 6288 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T441 | ECGU000441 | 0.09 |
| 6289 | PLTP levels | GCST90470262 | 0.09 |
| 6290 | TIMM10 levels | GCST90470867 | 0.09 |
| 6291 | DNPH1/NSFL1C ratio | GCST90314526 | 0.09 |
| 6292 | X-12411 levels | GCST90200492 | 0.09 |
| 6293 | AXL/MSR1 ratio | GCST90313422 | 0.09 |
| 6294 | ANXA3 levels | GCST90468318 | 0.09 |
| 6295 | SPTLC1 levels | GCST90427130 | 0.09 |
| 6296 | ELN levels | GCST90469103 | 0.09 |
| 6297 | RGCC levels | GCST90470461 | 0.09 |
| 6298 | CD164/PARK7 ratio | GCST90313743 | 0.09 |
| 6299 | Divergent concomitant strabismus | FING00000470 | 0.09 |
| 6300 | 3-methyl-2-oxovalerate levels | GCST90243485 | 0.09 |
| 6301 | Congenital iodine-deficiency syndrome/hypothyroidism | FING00000328 | 0.09 |
| 6302 | IDP dMRI ProbtrackX ICVF cst r | GCST90004384 | 0.09 |
| 6303 | Weight | Body size measures | UKBB00000909 | 0.09 |
| 6304 | Immature fraction of reticulocytes | GCST90025971 | 0.09 |
| 6305 | VAMP8 levels | GCST90471025 | 0.09 |
| 6306 | BCL2L1 levels | GCST90468432 | 0.09 |
| 6307 | ADAM12 levels | GCST90468216 | 0.09 |
| 6308 | IDP T1 FIRST right putamen volume | GCST90002441 | 0.09 |
| 6309 | GABBR2 levels | GCST90241230 | 0.09 |
| 6310 | LGMN levels | GCST90469766 | 0.09 |
| 6311 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86) | GCST90320649 | 0.09 |
| 6312 | CTSL levels | GCST90468914 | 0.09 |
| 6313 | Asthma | GCST010042 | 0.09 |
| 6314 | GPD1 levels | GCST90469388 | 0.09 |
| 6315 | Average diameter for HDL particles | GCST90092828 | 0.09 |
| 6316 | ERBB4 levels | GCST90469141 | 0.09 |
| 6317 | Hip circumference (UKB data field 49) | GCST90468170 | 0.09 |
| 6318 | Chronic airway obstruction (PheCode 496) | GCST90476027 | 0.09 |
| 6319 | Right bundle branch block (PheCode 426.31) | GCST90475957 | 0.09 |
| 6320 | 1-(1-enyl-palmitoyl)-GPC (p-16:0) levels | GCST90199899 | 0.09 |
| 6321 | Attention deficit hyperactivity disorder | GCST005362 | 0.09 |
| 6322 | Acne | FING00000010 | 0.09 |
| 6323 | Carotid artery plaque burden | GCST90503076 | 0.09 |
| 6324 | ThalamNuclei rh volume MGN | GCST90002737 | 0.09 |
| 6325 | YOD1 levels | GCST90471090 | 0.09 |
| 6326 | DNAJA2/SCAMP3 ratio | GCST90314507 | 0.09 |
| 6327 | Frailty (Factor 5 - Poorer Cognition) | GCST90624051 | 0.09 |
| 6328 | Myasthenia gravis | GCST90432156 | 0.09 |
| 6329 | NUDT5 levels | GCST90470107 | 0.09 |
| 6330 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 73) | GCST90320636 | 0.09 |
| 6331 | Peripheral vascular disease | GCST90475219 | 0.09 |
| 6332 | JPT2 levels | GCST90469663 | 0.09 |
| 6333 | Right-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302816 | 0.09 |
| 6334 | PSRC1/SMAD1 ratio | GCST90315741 | 0.09 |
| 6335 | Wheeze or whistling in the chest in last year (UKB data field 2316) | GCST90043614 | 0.09 |
| 6336 | TNFSF12 levels | GCST90470919 | 0.09 |
| 6337 | IDP dMRI TBSS L1 Anterior corona radiata R | GCST90004097 | 0.09 |
| 6338 | AIFM1/PLXNA4 ratio | GCST90313220 | 0.09 |
| 6339 | Pulmonary embolism and infarction, acute (PheCode 415.11) | GCST90475946 | 0.09 |
| 6340 | NADK/S100A11 ratio | GCST90315513 | 0.09 |
| 6341 | CDH17/GALNT3 ratio | GCST90313940 | 0.09 |
| 6342 | PHYKPL levels | GCST90470228 | 0.09 |
| 6343 | PTH levels | GCST90470372 | 0.09 |
| 6344 | Job involves mainly walking or standing | Employment | UKBB00000384 | 0.09 |
| 6345 | PEAR1/PECAM1 ratio | GCST90315641 | 0.09 |
| 6346 | CD84 levels | GCST90468653 | 0.09 |
| 6347 | ANPEP levels | GCST90468313 | 0.09 |
| 6348 | CUZD1 levels | GCST90468919 | 0.09 |
| 6349 | Diseases of esophagus (PheCode 530) | GCST90476045 | 0.09 |
| 6350 | NFKBIE levels | GCST90470039 | 0.09 |
| 6351 | LUZP2 levels | GCST90469819 | 0.09 |
| 6352 | Percentage of monosialylation of core-fucosylated monogalactosylated structures without bisecting GlcNAc (GP41) | GCST90668485 | 0.09 |
| 6353 | F3 levels | GCST90469170 | 0.09 |
| 6354 | Severe autoimmune type 2 diabetes | GCST90026412 | 0.09 |
| 6355 | Cerebrospinal fluid 3-hydroxy-2-ethylpropionate levels | GCST90317964 | 0.08 |
| 6356 | Follicle stimulating hormone levels | GCST90483476 | 0.08 |
| 6357 | Cholesteryl ester levels in HDL | GCST90092823 | 0.08 |
| 6358 | IFNGR1/IL10RB ratio | GCST90315127 | 0.08 |
| 6359 | AXIN1 levels | GCST90468405 | 0.08 |
| 6360 | ADAMTS15/SULT2A1 ratio | GCST90313171 | 0.08 |
| 6361 | FEN1 levels | GCST90469213 | 0.08 |
| 6362 | Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Asthma | Medical conditions | UKBB00000098 | 0.08 |
| 6363 | rfMRI amplitudes (ICA25 node 14) | GCST90004581 | 0.08 |
| 6364 | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) levels | GCST90200083 | 0.08 |
| 6365 | NID2 levels | GCST90470048 | 0.08 |
| 6366 | Concentration of medium HDL particles (UKB data field 23565) | GCST90269662 | 0.08 |
| 6367 | GNE levels | GCST90469370 | 0.08 |
| 6368 | CRKL/SERPINB1 ratio | GCST90314272 | 0.08 |
| 6369 | FOLR3/KLK8 ratio | GCST90314868 | 0.08 |
| 6370 | SERPINB6 levels | GCST90470591 | 0.08 |
| 6371 | DTI TBSS MD Retrolenticular part of internal capsule R | GCST90384592 | 0.08 |
| 6372 | SEPTIN8 levels | GCST90470578 | 0.08 |
| 6373 | wg lh intensity-contrast lingual | GCST90003804 | 0.08 |
| 6374 | IDP dMRI TBSS ISOVF Anterior corona radiata R | GCST90004499 | 0.08 |
| 6375 | TG levels | GCST90470851 | 0.08 |
| 6376 | DSG2 levels | GCST90423766 | 0.08 |
| 6377 | PPP1R12A/SKAP2 ratio | GCST90315710 | 0.08 |
| 6378 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T67 | ECGU000067 | 0.08 |
| 6379 | SCARA5/TGFBI ratio | GCST90315809 | 0.08 |
| 6380 | IgA nephropathy (IgA glomerulonephritis) | FING00000660 | 0.08 |
| 6381 | T1 CAT volume R RightAccumbens | GCST90384109 | 0.08 |
| 6382 | T1 FreeSurfer BA rh BA2 exvivo volume | GCST90385576 | 0.08 |
| 6383 | Bell pepper liking | GCST90094703 | 0.08 |
| 6384 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T485 | ECGU000485 | 0.08 |
| 6385 | Red blood cell count | GCST90002364 | 0.08 |
| 6386 | ITGB1BP2/TIA1 ratio | GCST90315222 | 0.08 |
| 6387 | CDC26 levels | GCST90468663 | 0.08 |
| 6388 | Severity of induration at injection site at the injection site after COVID-19 booster vaccination | GCST90454409 | 0.08 |
| 6389 | DTI TBSS MD Superior longitudinal fasciculus L | GCST90384613 | 0.08 |
| 6390 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T60 | ECGU000060 | 0.08 |
| 6391 | Cystitis | FING00000376 | 0.08 |
| 6392 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T487 | ECGA000487 | 0.08 |
| 6393 | IDP dMRI TBSS L1 Anterior limb of internal capsule R | GCST90004091 | 0.08 |
| 6394 | OGN levels | GCST90470119 | 0.08 |
| 6395 | CCN4 levels | GCST90468590 | 0.08 |
| 6396 | EREG/MPIG6B ratio | GCST90314704 | 0.08 |
| 6397 | CXCL10/CXCL11 ratio | GCST90314330 | 0.08 |
| 6398 | ACOT13 levels | GCST90468200 | 0.08 |
| 6399 | VGF levels | GCST90471038 | 0.08 |
| 6400 | CD27/ICAM3 ratio | GCST90313773 | 0.08 |
| 6401 | CA2/CA3 ratio | GCST90313576 | 0.08 |
| 6402 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T489 | ECGA000489 | 0.08 |
| 6403 | Total protein levels | GCST90468105 | 0.08 |
| 6404 | IQGAP2/STX4 ratio | GCST90315190 | 0.08 |
| 6405 | F-cooking vegetables liking (derived food-liking factor) | GCST90094743 | 0.08 |
| 6406 | Myasthenia gravis | GCST90093061 | 0.08 |
| 6407 | Principal component-derived dietary pattern 31 | GCST90133036 | 0.08 |
| 6408 | AmygNuclei rh volume Accessory-Basal-nucleus | GCST90002660 | 0.08 |
| 6409 | PMVK/RHOC ratio | GCST90315697 | 0.08 |
| 6410 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T464 | ECGA000464 | 0.08 |
| 6411 | SIRPB1 levels | GCST90470640 | 0.08 |
| 6412 | MAP2 levels | GCST90469853 | 0.08 |
| 6413 | Volume of right paralaminar nucleus | GCST90475048 | 0.08 |
| 6414 | Docosahexaenoic acid levels | GCST90497256 | 0.08 |
| 6415 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T90 | ECGU000090 | 0.08 |
| 6416 | MANSC1 levels | GCST90469847 | 0.08 |
| 6417 | SNCA levels | GCST90470694 | 0.08 |
| 6418 | DTI TBSS L2 Posterior thalamic radiation L | GCST90384505 | 0.08 |
| 6419 | Phospholipids to Total Lipids in Very Small VLDL percentage | GCST90500856 | 0.08 |
| 6420 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T234 | ECGU000234 | 0.08 |
| 6421 | PPIB levels | GCST90470291 | 0.08 |
| 6422 | ATRN levels | GCST90468400 | 0.08 |
| 6423 | DDX58 levels | GCST90468977 | 0.08 |
| 6424 | GCG levels | GCST90469316 | 0.08 |
| 6425 | NFU1 levels | GCST90470040 | 0.08 |
| 6426 | Valine levels | GCST90500176 | 0.08 |
| 6427 | Diacylglycerol_36:5_[M+H-H2O]1+ levels | GCST90060187 | 0.08 |
| 6428 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T425 | ECGU000425 | 0.08 |
| 6429 | VASP levels | GCST90471028 | 0.08 |
| 6430 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86) | GCST90320905 | 0.08 |
| 6431 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T482 | ECGA000482 | 0.08 |
| 6432 | IDP dMRI TBSS ICVF Middle cerebellar peduncle | GCST90004327 | 0.08 |
| 6433 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502075 | 0.08 |
| 6434 | Malignant neoplasm of bladder (PheCode 189.21) | GCST90475599 | 0.08 |
| 6435 | Left-hemisphere dorsal attention network to left-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302690 | 0.08 |
| 6436 | MGMT levels | GCST90469902 | 0.08 |
| 6437 | Prescriptions - opioid analgesic|selective serotonin re-uptake inhibitor|norepinephrine re-uptake inhibitor | UKBB00000694 | 0.08 |
| 6438 | Prescriptions - tramadol | opioid analgesic,selective serotonin re-uptake inhibitor,norepinephrine re-uptake inhibitor | UKBB00000706 | 0.08 |
| 6439 | SERPINB1 levels | GCST90470589 | 0.08 |
| 6440 | ERP44/SUMF2 ratio | GCST90314710 | 0.08 |
| 6441 | PPP2R5A levels | GCST90470306 | 0.08 |
| 6442 | X-13671 levels | GCST90243829 | 0.08 |
| 6443 | LAT2/MANF ratio | GCST90315277 | 0.08 |
| 6444 | Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers) | FING00000756 | 0.08 |
| 6445 | BTD levels | GCST90468477 | 0.08 |
| 6446 | PPP1R12A levels | GCST90470300 | 0.08 |
| 6447 | Neutrophil count | GCST90002398 | 0.08 |
| 6448 | ECHDC3 levels | GCST90469062 | 0.08 |
| 6449 | INPP1 levels | GCST90469616 | 0.08 |
| 6450 | APOM/ERBB3 ratio | GCST90313314 | 0.08 |
| 6451 | FHIT/MAX ratio | GCST90314818 | 0.08 |
| 6452 | Minimum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000477 | 0.08 |
| 6453 | GRAP2/SNX9 ratio | GCST90314988 | 0.07 |
| 6454 | BPIFB1 levels | GCST90468462 | 0.07 |
| 6455 | MICB_MICA/TEK ratio | GCST90315446 | 0.07 |
| 6456 | IDP dMRI TBSS FA Sagittal stratum R | GCST90003907 | 0.07 |
| 6457 | Zoster infection | GCST90018721 | 0.07 |
| 6458 | aparc-a2009s lh volume G-pariet-inf-Supramar | GCST90002950 | 0.07 |
| 6459 | Wegener granulomatosis | FING00001446 | 0.07 |
| 6460 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T101 | ECGU000101 | 0.07 |
| 6461 | White blood cell count | GCST90002375 | 0.07 |
| 6462 | IDP dMRI ProbtrackX L1 cgc r | GCST90004251 | 0.07 |
| 6463 | CXCL8 levels | GCST90468934 | 0.07 |
| 6464 | Total lipids in very small VLDL | GCST90500810 | 0.07 |
| 6465 | ITGA5/LILRA2 ratio | GCST90315204 | 0.07 |
| 6466 | Cirrhosis | GCST90018606 | 0.07 |
| 6467 | HippSubfield lh volume subiculum-body | GCST90002669 | 0.07 |
| 6468 | MECR levels | GCST90469879 | 0.07 |
| 6469 | CASP8/SEPTIN9 ratio | GCST90313658 | 0.07 |
| 6470 | Chronic pancreatitis | GCST90018601 | 0.07 |
| 6471 | PAK4 levels | GCST90470150 | 0.07 |
| 6472 | Free cholesterol levels in large HDL | GCST90092848 | 0.07 |
| 6473 | PDGFA/SNAP23 ratio | GCST90315619 | 0.07 |
| 6474 | TAX1BP3 levels | GCST90242976 | 0.07 |
| 6475 | BMI (weighted GWA) | GCST90267269 | 0.07 |
| 6476 | CCL20 levels | GCST90012077 | 0.07 |
| 6477 | Tea intake (UKB data field 1488) | GCST90132983 | 0.07 |
| 6478 | PRKRA levels | GCST90470331 | 0.07 |
| 6479 | aparc-Desikan lh area superiorparietal | GCST90003101 | 0.07 |
| 6480 | RNF5 levels | GCST90470488 | 0.07 |
| 6481 | Cholesterol in medium HDL (UKB data field 23568) | GCST90269665 | 0.07 |
| 6482 | Free Cholesterol to Total Lipids in Very Small VLDL percentage | GCST90500798 | 0.07 |
| 6483 | ITGB1BP2/LAT2 ratio | GCST90315212 | 0.07 |
| 6484 | Nephritis and nephropathy without mention of glomerulonephritis (PheCode 580.3) | GCST90476115 | 0.07 |
| 6485 | IST1 levels | GCST90469632 | 0.07 |
| 6486 | FGF19/SCG2 ratio | GCST90314809 | 0.07 |
| 6487 | ABL1/CC2D1A ratio | GCST90313148 | 0.07 |
| 6488 | F2R levels | GCST90012010 | 0.07 |
| 6489 | CPB1 levels | GCST90240597 | 0.07 |
| 6490 | CD69/F2R ratio | GCST90313877 | 0.07 |
| 6491 | MEGF9/MET ratio | GCST90315418 | 0.07 |
| 6492 | IDP dMRI ProbtrackX ICVF atr r | GCST90004378 | 0.07 |
| 6493 | IDP T1 FAST ROIs R cerebellum X | GCST90002589 | 0.07 |
| 6494 | wg lh intensity-contrast lateralorbitofrontal | GCST90003803 | 0.07 |
| 6495 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T490 | ECGU000490 | 0.07 |
| 6496 | IDP T1 FIRST left hippocampus volume | GCST90002444 | 0.07 |
| 6497 | Phospholipids to total lipids ratio in medium HDL | GCST90092901 | 0.07 |
| 6498 | S100A13 levels | GCST90470514 | 0.07 |
| 6499 | SNCA levels | GCST90240258 | 0.07 |
| 6500 | DTI autoptx L2 ilf l tract | GCST90385180 | 0.07 |
| 6501 | MAX/STK24 ratio | GCST90315404 | 0.07 |
| 6502 | IDP T1 FAST ROIs L cerebellum VIIIb | GCST90002581 | 0.07 |
| 6503 | Free cholesterol to total lipids in large VLDL percentage (UKB data field 23592) | GCST90269689 | 0.07 |
| 6504 | EREG/F2R ratio | GCST90314700 | 0.07 |
| 6505 | aparc-Desikan rh area parstriangularis | GCST90003126 | 0.07 |
| 6506 | X-13435 levels | GCST90243811 | 0.07 |
| 6507 | IDP dMRI TBSS L1 Anterior limb of internal capsule L | GCST90004092 | 0.07 |
| 6508 | AFP levels | GCST90278615 | 0.07 |
| 6509 | DKK1/VEGFA ratio | GCST90314483 | 0.07 |
| 6510 | Acetone levels (UKB data field 23477) | GCST90269574 | 0.07 |
| 6511 | FCRL5/MZB1 ratio | GCST90314804 | 0.07 |
| 6512 | EIF3J levels | GCST90241122 | 0.07 |
| 6513 | PNLIP levels | GCST90470275 | 0.07 |
| 6514 | Concentration of very small VLDL particles | GCST90500819 | 0.07 |
| 6515 | Left-hemisphere default mode network to accumbens white-matter structural connectivity | GCST90302773 | 0.07 |
| 6516 | IDP dMRI TBSS MO Pontine crossing tract | GCST90003953 | 0.07 |
| 6517 | ILKAP levels | GCST90469608 | 0.07 |
| 6518 | Phosphatidylethanolamine_40:6_[M-H]1- levels | GCST90060365 | 0.07 |
| 6519 | Testosterone levels (UKB data field 30850) | GCST90468103 | 0.07 |
| 6520 | X-12038 levels | GCST90243683 | 0.07 |
| 6521 | Alpha-hydroxyisovalerate levels | GCST90199736 | 0.07 |
| 6522 | Omega-3 fatty acids to total fatty acids percentage | GCST90502466 | 0.07 |
| 6523 | TIGIT levels | GCST90470865 | 0.07 |
| 6524 | Bread consumption (slices per week) (UKB data field 1438) | GCST90132981 | 0.07 |
| 6525 | CD163/SIGLEC1 ratio | GCST90313739 | 0.07 |
| 6526 | Body mass index | GCST90018727 | 0.07 |
| 6527 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T426 | ECGU000426 | 0.07 |
| 6528 | rfMRI connectivity (ICA100 edge 495) | GCST90005348 | 0.07 |
| 6529 | EBAG9/FKBP5 ratio | GCST90314564 | 0.07 |
| 6530 | Glucose | Blood biochemistry | UKBB00000288 | 0.07 |
| 6531 | X-12063 levels | GCST90243687 | 0.07 |
| 6532 | PATE4 levels | GCST90242405 | 0.07 |
| 6533 | PDLIM7 levels | GCST90470198 | 0.07 |
| 6534 | STIP1 levels | GCST90470764 | 0.07 |
| 6535 | Acceptance of an invitation to wear a physical activity monitor | GCST90012791 | 0.07 |
| 6536 | FGA levels | GCST90469216 | 0.07 |
| 6537 | GGT5 levels | GCST90469337 | 0.07 |
| 6538 | ASRGL1 levels | GCST90468379 | 0.07 |
| 6539 | Alanine levels | GCST90497086 | 0.07 |
| 6540 | CCL8 levels | GCST90468586 | 0.07 |
| 6541 | Smoking status - Never | Smoking | UKBB00000780 | 0.07 |
| 6542 | Testosterone levels | GCST90483487 | 0.07 |
| 6543 | DTI TBSS L2 Superior longitudinal fasciculus L | GCST90384517 | 0.07 |
| 6544 | aseg global volume CC-Posterior | GCST90002607 | 0.07 |
| 6545 | Dihomo-linoleoylcarnitine (C20:2) levels | GCST90200144 | 0.07 |
| 6546 | Estimated glomerular filtration rate based on creatinine and cystatin C in bottom 99% of individuals by creatinine levels | GCST90566737 | 0.07 |
| 6547 | Malignant melanoma | GCST90468141 | 0.07 |
| 6548 | CDH2/CDHR2 ratio | GCST90313950 | 0.07 |
| 6549 | MAD1L1 levels | GCST90469836 | 0.07 |
| 6550 | CPB1/CTRB1 ratio | GCST90314208 | 0.07 |
| 6551 | Physical activity (Relative amplitude) | GCST90061432 | 0.07 |
| 6552 | IDP dMRI ProbtrackX L1 atr l | GCST90004248 | 0.07 |
| 6553 | Alzheimer's disease (MTAG) | GCST90449053 | 0.07 |
| 6554 | FABP1 levels | GCST90469173 | 0.07 |
| 6555 | PPT1 levels | GCST90427718 | 0.07 |
| 6556 | CD79B levels | GCST90468648 | 0.07 |
| 6557 | SULT1A1 levels | GCST90470781 | 0.07 |
| 6558 | IDP dMRI TBSS L1 Posterior limb of internal capsule R | GCST90004093 | 0.07 |
| 6559 | MIF levels | GCST90089018 | 0.07 |
| 6560 | Triglycerides x low social support interaction (2df test) | GCST90570681 | 0.07 |
| 6561 | CRKL levels | GCST90468867 | 0.07 |
| 6562 | EIF4B levels | GCST90469094 | 0.07 |
| 6563 | IDP dMRI TBSS OD Cerebral peduncle L | GCST90004417 | 0.07 |
| 6564 | Asthma with exacerbation (PheCode 495.2) | GCST90476025 | 0.07 |
| 6565 | STAT5B levels | GCST90470759 | 0.06 |
| 6566 | DBI levels | GCST90468949 | 0.06 |
| 6567 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T102 | ECGU000102 | 0.06 |
| 6568 | FXYD5 levels | GCST90469283 | 0.06 |
| 6569 | IDP dMRI TBSS MD Splenium of corpus callosum | GCST90004031 | 0.06 |
| 6570 | Turnip liking | GCST90094861 | 0.06 |
| 6571 | ESM1 levels | GCST90012068 | 0.06 |
| 6572 | COPD | FING00000350 | 0.06 |
| 6573 | TMSB10/TXNRD1 ratio | GCST90315925 | 0.06 |
| 6574 | PDGFB/SPINT2 ratio | GCST90315629 | 0.06 |
| 6575 | SPARC/TJAP1 ratio | GCST90315873 | 0.06 |
| 6576 | SNAP29/SNX9 ratio | GCST90315859 | 0.06 |
| 6577 | KAZN levels | GCST90469666 | 0.06 |
| 6578 | HS1BP3 levels | GCST90469477 | 0.06 |
| 6579 | F-strong vegetable liking (derived food-liking factor) | GCST90094852 | 0.06 |
| 6580 | QDPR/THOP1 ratio | GCST90315757 | 0.06 |
| 6581 | CANT1/VSIR ratio | GCST90313621 | 0.06 |
| 6582 | IDP dMRI TBSS MD Body of corpus callosum | GCST90004030 | 0.06 |
| 6583 | CD14 levels | GCST90468598 | 0.06 |
| 6584 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T474 | ECGA000474 | 0.06 |
| 6585 | Omega-6 fatty acid levels | GCST90502094 | 0.06 |
| 6586 | DTI TBSS L3 Superior corona radiata R | GCST90384548 | 0.06 |
| 6587 | CYTL1 levels | GCST90468940 | 0.06 |
| 6588 | Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers) | FING00000143 | 0.06 |
| 6589 | Cholesteryl ester_18:0_[M+NH4]1+ levels | GCST90060222 | 0.06 |
| 6590 | PNMA1 levels | GCST90470276 | 0.06 |
| 6591 | ANGPT1/PDGFA ratio | GCST90313266 | 0.06 |
| 6592 | CXCL12/TIMP3 ratio | GCST90314338 | 0.06 |
| 6593 | CLEC4D/CLEC6A ratio | GCST90314109 | 0.06 |
| 6594 | Other chondrocalcinosis | FING00000977 | 0.06 |
| 6595 | TARBP2/TDRKH ratio | GCST90315902 | 0.06 |
| 6596 | Triacylglycerol_51:3_[M+NH4]1+ levels | GCST90060494 | 0.06 |
| 6597 | N6-acetyllysine levels in chronic kidney disease | GCST90257531 | 0.06 |
| 6598 | CDHR1 levels | GCST90468678 | 0.06 |
| 6599 | PSME1 levels | GCST90470360 | 0.06 |
| 6600 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T52 | ECGA000052 | 0.06 |
| 6601 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T494 | ECGU000494 | 0.06 |
| 6602 | PDGFA/VEGFC ratio | GCST90315622 | 0.06 |
| 6603 | MAP4K5 levels | GCST90469855 | 0.06 |
| 6604 | IKBKG levels | GCST90469542 | 0.06 |
| 6605 | GKN2 levels | GCST90089413 | 0.06 |
| 6606 | Handedness (chirality/laterality) - Right-handed | Early life factors | UKBB00000303 | 0.06 |
| 6607 | Milk type used - Skimmed | Diet | UKBB00000470 | 0.06 |
| 6608 | SCAMP3/VPS53 ratio | GCST90315807 | 0.06 |
| 6609 | IDP T1 FAST ROIs L cerebellum VIIb | GCST90002575 | 0.06 |
| 6610 | PGD levels | GCST90470217 | 0.06 |
| 6611 | Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+NH4]1+ levels | GCST90060270 | 0.06 |
| 6612 | TJAP1 levels | GCST90470874 | 0.06 |
| 6613 | Sjögren's syndrome | GCST90018700 | 0.06 |
| 6614 | NTRK3/SCARF2 ratio | GCST90315571 | 0.06 |
| 6615 | IDP T1 FAST ROIs R hippocampus | GCST90002556 | 0.06 |
| 6616 | Open wounds of extremities (PheCode 871) | GCST90476285 | 0.06 |
| 6617 | EDAR/TACC3 ratio | GCST90314589 | 0.06 |
| 6618 | Gestational [pregnancy-induced] hypertension | FING00000571 | 0.06 |
| 6619 | Linoleic acid to total fatty acids percentage | GCST90502333 | 0.06 |
| 6620 | GFER levels | GCST90469326 | 0.06 |
| 6621 | DTI TBSS MO Pontine crossing tract | GCST90384621 | 0.06 |
| 6622 | GRAP2/MAP4K5 ratio | GCST90314982 | 0.06 |
| 6623 | DKK1/VASH1 ratio | GCST90314482 | 0.06 |
| 6624 | Other noninfective gastroenteritis and colitis | FING00001077 | 0.06 |
| 6625 | DTI TBSS L3 Posterior corona radiata R | GCST90384550 | 0.06 |
| 6626 | NSFL1C/PSMG3 ratio | GCST90315559 | 0.06 |
| 6627 | APOB/APOA1 ratio | GCST90269538 | 0.06 |
| 6628 | LMNB2 levels | GCST90469782 | 0.06 |
| 6629 | CASP8/RILP ratio | GCST90313657 | 0.06 |
| 6630 | Diastolic blood pressure x sex interaction | GCST90335175 | 0.06 |
| 6631 | ICD10 C50.9: Malignant neoplasm of breast of unspecified site | GCST90043889 | 0.06 |
| 6632 | aparc-pial rh area lateralorbitofrontal | GCST90003185 | 0.06 |
| 6633 | Illnesses of siblings - Heart disease | Family history | UKBB00000351 | 0.06 |
| 6634 | aparc-a2009s rh area S-oc-middle+Lunatus | GCST90003427 | 0.06 |
| 6635 | RND3 levels | GCST90422230 | 0.06 |
| 6636 | TFPI2 levels | GCST90470838 | 0.06 |
| 6637 | Bitter ale liking | GCST90094705 | 0.06 |
| 6638 | CXCL5/PLXNA4 ratio | GCST90314351 | 0.06 |
| 6639 | aseg lh intensity Cerebellum-Cortex | GCST90003767 | 0.06 |
| 6640 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T94 | ECGU000094 | 0.06 |
| 6641 | FKBP4 levels | GCST90469243 | 0.06 |
| 6642 | FABP9 levels | GCST90469179 | 0.06 |
| 6643 | LGALS8/TXNDC5 ratio | GCST90315321 | 0.06 |
| 6644 | DTI autoptx L3 slf r tract | GCST90385215 | 0.06 |
| 6645 | ART3/RGMB ratio | GCST90313363 | 0.06 |
| 6646 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T442 | ECGU000442 | 0.06 |
| 6647 | TNFSF14 levels | GCST90274842 | 0.06 |
| 6648 | TPMT levels | GCST90470945 | 0.06 |
| 6649 | F-healthy food liking (derived food-liking factor) | GCST90094779 | 0.06 |
| 6650 | EDAR/TNFSF12 ratio | GCST90314591 | 0.06 |
| 6651 | Volume of right lateral nucleus | GCST90474922 | 0.06 |
| 6652 | CNPY4/STAT5B ratio | GCST90314155 | 0.06 |
| 6653 | Milk chocolate liking | GCST90094801 | 0.06 |
| 6654 | NDUFB7 levels | GCST90470015 | 0.06 |
| 6655 | N-acetylglycine levels | GCST90243561 | 0.06 |
| 6656 | Cholesterol to total lipids ratio in chylomicrons and extremely large VLDL | GCST90093041 | 0.06 |
| 6657 | RND3 levels | GCST90618066 | 0.06 |
| 6658 | VEGFA levels | GCST90471034 | 0.06 |
| 6659 | CCL17/PDGFB ratio | GCST90313688 | 0.06 |
| 6660 | PLIN3/VSIR ratio | GCST90315679 | 0.06 |
| 6661 | ITGB1/NCAM1 ratio | GCST90315227 | 0.06 |
| 6662 | Shortness of breath (PheCode 512.7) | GCST90476040 | 0.06 |
| 6663 | Omega-3 fatty acids to total fatty acids percentage | GCST90502463 | 0.06 |
| 6664 | creatinine (maximum, inv-norm transformed) | GCST90475226 | 0.06 |
| 6665 | Total testosterone levels | GCST90012112 | 0.06 |
| 6666 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T78 | ECGU000078 | 0.06 |
| 6667 | Left eye overall retinal pigment epithelium thickness | GCST90672032 | 0.06 |
| 6668 | ANXA4/HSPB1 ratio | GCST90313292 | 0.06 |
| 6669 | Bone marrow fat fraction of lumbar vertebra 4 | GCST90652389 | 0.06 |
| 6670 | FKBP4/FKBP5 ratio | GCST90314838 | 0.06 |
| 6671 | Sleep disorders | neurological | UKBB00000776 | 0.06 |
| 6672 | HYOU1 levels | GCST90469496 | 0.06 |
| 6673 | SELP/VSIR ratio | GCST90315822 | 0.06 |
| 6674 | LSIL lesion of the cervix uteri, vagina or vulva | FING00000733 | 0.06 |
| 6675 | Lactose intolerance, other/unspecified | FING00000712 | 0.06 |
| 6676 | Hot drink temperature | Diet | UKBB00000329 | 0.06 |
| 6677 | IGSF8/VSIR ratio | GCST90315141 | 0.06 |
| 6678 | Frailty (Factor 4 - Metabolic Problems) | GCST90624050 | 0.06 |
| 6679 | CA6/DNER ratio | GCST90313594 | 0.06 |
| 6680 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T471 | ECGU000471 | 0.06 |
| 6681 | Average diameter for HDL particles (UKB data field 23433) | GCST90269530 | 0.06 |
| 6682 | CD40LG/EDAR ratio | GCST90313818 | 0.06 |
| 6683 | Effects radiation NOS (PheCode 990) | GCST90476293 | 0.05 |
| 6684 | DTI TBSS L3 Fornix | GCST90384529 | 0.05 |
| 6685 | Parkinson's disease or first degree relation to individual with Parkinson's disease | GCST009325 | 0.05 |
| 6686 | Volume of left whole amygdala | GCST90474986 | 0.05 |
| 6687 | Type 2 diabetes | GCST90086071 | 0.05 |
| 6688 | Degeneration of intervertebral disc (PheCode 722.6) | GCST90476238 | 0.05 |
| 6689 | AXL/GAS6 ratio | GCST90313419 | 0.05 |
| 6690 | aparc-Desikan rh volume postcentral | GCST90002822 | 0.05 |
| 6691 | Breast cancer | GCST007236 | 0.05 |
| 6692 | aseg rh intensity Cerebellum-Cortex | GCST90003781 | 0.05 |
| 6693 | MTIF3 levels | GCST90469957 | 0.05 |
| 6694 | Alkenylphosphatidylcholine (P-16:0/16:0) levels | GCST90025563 | 0.05 |
| 6695 | HEXIM1/IPCEF1 ratio | GCST90315046 | 0.05 |
| 6696 | Seborrhoeic keratosis | FING00001283 | 0.05 |
| 6697 | Basal cell carcinoma, excluding all cancers (controls excluding all cancers) | FING00000142 | 0.05 |
| 6698 | SPINK4 levels | GCST90470723 | 0.05 |
| 6699 | Principal component-derived dietary pattern 46 | GCST90133051 | 0.05 |
| 6700 | PCBD1 levels | GCST90470166 | 0.05 |
| 6701 | Histidine levels | GCST90092830 | 0.05 |
| 6702 | Height decline (difference score) | GCST90565863 | 0.05 |
| 6703 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T459 | ECGU000459 | 0.05 |
| 6704 | NADK levels | GCST90469993 | 0.05 |
| 6705 | Dissociative [conversion] disorders | FING00000468 | 0.05 |
| 6706 | rfMRI amplitudes (ICA100 node 2) | GCST90004590 | 0.05 |
| 6707 | IL1R1 levels | GCST90469571 | 0.05 |
| 6708 | ADAM23 levels | GCST90468219 | 0.05 |
| 6709 | Glycoprotein acetyls levels | GCST90497328 | 0.05 |
| 6710 | CCL17/CD69 ratio | GCST90313684 | 0.05 |
| 6711 | IDP dMRI TBSS L1 Superior longitudinal fasciculus L | GCST90004116 | 0.05 |
| 6712 | Hayfever | GCST90468131 | 0.05 |
| 6713 | Lysophosphatidylcholine (26:0) [sn2] levels | GCST90025428 | 0.05 |
| 6714 | DBNL/HEXIM1 ratio | GCST90314417 | 0.05 |
| 6715 | PAM levels | GCST90470156 | 0.05 |
| 6716 | Non-ischemic cardiomyopathy | FING00000873 | 0.05 |
| 6717 | rfMRI connectivity (ICA100 edge 995) | GCST90005848 | 0.05 |
| 6718 | Other diseases of blood and blood-forming organs | FING00000998 | 0.05 |
| 6719 | CLEC7A levels | GCST90468778 | 0.05 |
| 6720 | ADAMTS4 levels | GCST90468226 | 0.05 |
| 6721 | Urinary albumin-to-creatinine ratio | GCST009640 | 0.05 |
| 6722 | Histidine levels (UKB data field 23463) | GCST90269560 | 0.05 |
| 6723 | CD244/CD84 ratio | GCST90313762 | 0.05 |
| 6724 | Mean carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasound | UKBB00000446 | 0.05 |
| 6725 | Cholesteryl ester levels in large HDL | GCST90092846 | 0.05 |
| 6726 | aparc-Desikan rh volume fusiform | GCST90002807 | 0.05 |
| 6727 | HMOX2/TDRKH ratio | GCST90315067 | 0.05 |
| 6728 | Gestational diabetes (for exclusion) | FING00000573 | 0.05 |
| 6729 | C1QTNF1 levels | GCST90468488 | 0.05 |
| 6730 | IDP dMRI TBSS OD Pontine crossing tract | GCST90004403 | 0.05 |
| 6731 | White blood cell count | GCST90025985 | 0.05 |
| 6732 | In your lifetime, have you smoked a total of at least 100 cigarettes? | GCST90476387 | 0.05 |
| 6733 | Disorders of breast | FING00000437 | 0.05 |
| 6734 | Cystatin C levels in bottom 99% of individuals by creatinine levels | GCST90566734 | 0.05 |
| 6735 | Social trust (aggregated) | GCST90319315 | 0.05 |
| 6736 | GMFG levels | GCST90469366 | 0.05 |
| 6737 | Lymphocyte count | GCST90002317 | 0.05 |
| 6738 | AmygNuclei rh volume Central-nucleus | GCST90002662 | 0.05 |
| 6739 | ARHGEF1 levels | GCST90468359 | 0.05 |
| 6740 | Androstenediol (3alpha, 17alpha) monosulfate (3) levels | GCST90199856 | 0.05 |
| 6741 | LTB4R levels | GCST90422164 | 0.05 |
| 6742 | DHX58 levels | GCST90618238 | 0.05 |
| 6743 | OMD/SPP1 ratio | GCST90315586 | 0.05 |
| 6744 | SERPINH1 levels | GCST90470601 | 0.05 |
| 6745 | Butyrylcarnitine levels | GCST90243589 | 0.05 |
| 6746 | Unspecified dementia | FING00001400 | 0.05 |
| 6747 | BACH1/SNX9 ratio | GCST90313447 | 0.05 |
| 6748 | Ulcerative rectosigmoiditis | FING00001394 | 0.05 |
| 6749 | DUT levels | GCST90469054 | 0.05 |
| 6750 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T89 | ECGU000089 | 0.05 |
| 6751 | Retinal thickness (functional principal component 4) | GCST90455724 | 0.05 |
| 6752 | LYN/YES1 ratio | GCST90315351 | 0.05 |
| 6753 | Acetone levels | GCST90092805 | 0.05 |
| 6754 | FLT3LG levels | GCST90469250 | 0.05 |
| 6755 | IL7 levels | GCST90469606 | 0.05 |
| 6756 | NUB1 levels | GCST90470099 | 0.05 |
| 6757 | SARG levels | GCST90470526 | 0.05 |
| 6758 | DBI/TMSB10 ratio | GCST90314414 | 0.05 |
| 6759 | PEAR1/SNAP23 ratio | GCST90315643 | 0.05 |
| 6760 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T433 | ECGU000433 | 0.05 |
| 6761 | aparc-pial lh area supramarginal | GCST90003171 | 0.05 |
| 6762 | DNAJA2/FIS1 ratio | GCST90314501 | 0.05 |
| 6763 | Inflammatory markers and poor diet (confirmatory factor analysis Factor 30) | GCST90309364 | 0.05 |
| 6764 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T458 | ECGU000458 | 0.05 |
| 6765 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T476 | ECGU000476 | 0.05 |
| 6766 | F-savour/caloric food liking (derived food-liking factor) | GCST90094835 | 0.05 |
| 6767 | ADGRE5/ITGB2 ratio | GCST90313180 | 0.05 |
| 6768 | Takes medication for acid reflux/GERD? | GCST90475321 | 0.05 |
| 6769 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T468 | ECGA000468 | 0.05 |
| 6770 | Insomnia (weighted GWA) | GCST90267287 | 0.05 |
| 6771 | Sleep apnea (MTAG) | GCST90267362 | 0.05 |
| 6772 | 3-hydroxybutyrate levels (UKB data field 23474) | GCST90269571 | 0.05 |
| 6773 | Glucose levels | GCST90132724 | 0.05 |
| 6774 | Methods of admission to hospital (recoded) - Emergency admission: A&E | Summary Administration | UKBB00000464 | 0.05 |
| 6775 | IDP dMRI TBSS MO Cerebral peduncle L | GCST90003967 | 0.05 |
| 6776 | Principal component-derived dietary pattern 3 | GCST90133008 | 0.05 |
| 6777 | PEAR1 levels | GCST90470204 | 0.05 |
| 6778 | ERBB4/F3 ratio | GCST90314690 | 0.05 |
| 6779 | EFNA4/LAYN ratio | GCST90314602 | 0.05 |
| 6780 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502411 | 0.05 |
| 6781 | Urine glycine conjugate of C10H14O2 (1)* levels in chronic kidney disease | GCST90265274 | 0.05 |
| 6782 | SLC39A14 levels | GCST90470660 | 0.05 |
| 6783 | T1 FreeSurfer DKT rh supramarginal volume | GCST90384377 | 0.05 |
| 6784 | NPHS2 levels | GCST90470071 | 0.05 |
| 6785 | CA9/CBLIF ratio | GCST90313595 | 0.05 |
| 6786 | Leucine levels (UKB data field 23466) | GCST90269563 | 0.05 |
| 6787 | KIF22 levels | GCST90469682 | 0.05 |
| 6788 | wg lh intensity-contrast rostralmiddlefrontal | GCST90003818 | 0.05 |
| 6789 | Alkenylphosphatidylethanolamine (P-20:0/18:2) levels | GCST90025056 | 0.05 |
| 6790 | Fracture of shoulder and upper arm | FING00000559 | 0.05 |
| 6791 | DRG2 levels | GCST90469039 | 0.05 |
| 6792 | Platelet count | GCST90278640 | 0.05 |
| 6793 | DTI autoptx FA slf r tract | GCST90385134 | 0.05 |
| 6794 | LEPR/NRCAM ratio | GCST90315312 | 0.05 |
| 6795 | DTI TBSS FA Sagittal stratum L | GCST90384411 | 0.05 |
| 6796 | CD58/SIRPB1 ratio | GCST90313855 | 0.05 |
| 6797 | Phospholipids to total lipids in medium HDL percentage (UKB data field 23639) | GCST90269736 | 0.05 |
| 6798 | LY6D/NECTIN4 ratio | GCST90315344 | 0.05 |
| 6799 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T80 | ECGA000080 | 0.05 |
| 6800 | ANXA1 levels | GCST90240296 | 0.05 |
| 6801 | Cholesterol to total lipids ratio in very large HDL | GCST90093005 | 0.05 |
| 6802 | Left-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302658 | 0.05 |
| 6803 | ITGB6 levels | GCST90469646 | 0.05 |
| 6804 | IGF2R/LGMN ratio | GCST90315131 | 0.05 |
| 6805 | EIF4E levels | GCST90469096 | 0.05 |
| 6806 | rfMRI amplitudes (ICA100 node 7) | GCST90004595 | 0.05 |
| 6807 | MIF/PARK7 ratio | GCST90315447 | 0.05 |
| 6808 | AXL/VCAM1 ratio | GCST90313423 | 0.05 |
| 6809 | MESD/SNX9 ratio | GCST90315423 | 0.05 |
| 6810 | GLRX5 levels | GCST90469361 | 0.05 |
| 6811 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T75 | ECGU000075 | 0.05 |
| 6812 | Phospholipids to total lipids in very small VLDL percentage (UKB data field 23604) | GCST90269701 | 0.05 |
| 6813 | Wheeze or whistling in the chest in last year | Breathing | UKBB00000912 | 0.05 |
| 6814 | Facial ageing | Sun exposure | UKBB00000233 | 0.05 |
| 6815 | rfMRI connectivity ICA-features 1 | GCST90006339 | 0.05 |
| 6816 | IGSF9 levels | GCST90469541 | 0.05 |
| 6817 | KLK8/LY6D ratio | GCST90315257 | 0.05 |
| 6818 | PDCD6 levels | GCST90470183 | 0.05 |
| 6819 | T1 FreeSurfer BA lh V2 exvivo thickness | GCST90385529 | 0.05 |
| 6820 | FAM3B/FGF19 ratio | GCST90314776 | 0.05 |
| 6821 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T463 | ECGA000463 | 0.05 |
| 6822 | P4HB/PPP1R12A ratio | GCST90315591 | 0.05 |
| 6823 | HSIL lesion of the vulva | FING00000626 | 0.05 |
| 6824 | DTYMK levels | GCST90469049 | 0.05 |
| 6825 | IDP dMRI TBSS OD Posterior limb of internal capsule L | GCST90004421 | 0.05 |
| 6826 | TREH levels | GCST90470959 | 0.05 |
| 6827 | Diacylglycerol_36:4_[M+H-H2O]1+ levels | GCST90060188 | 0.05 |
| 6828 | NFASC levels | GCST90470031 | 0.05 |
| 6829 | TBCC/WWP2 ratio | GCST90315911 | 0.05 |
| 6830 | wg lh intensity-contrast postcentral | GCST90003813 | 0.05 |
| 6831 | Gamma glutamyl transferase levels | GCST90278630 | 0.05 |
| 6832 | LIPF levels | GCST90469780 | 0.05 |
| 6833 | PDGFB/ST6GAL1 ratio | GCST90315630 | 0.05 |
| 6834 | Liver fat | GCST90029073 | 0.05 |
| 6835 | SPRR3 levels | GCST90470737 | 0.05 |
| 6836 | CD69/CLEC1B ratio | GCST90313869 | 0.05 |
| 6837 | PPIF levels | GCST90470293 | 0.04 |
| 6838 | CD84/TREML2 ratio | GCST90313919 | 0.04 |
| 6839 | IRF2 levels | GCST90241566 | 0.04 |
| 6840 | Principal component-derived dietary pattern 32 | GCST90133037 | 0.04 |
| 6841 | IL6ST/LEPR ratio | GCST90315165 | 0.04 |
| 6842 | Liver enzyme levels (alanine transaminase) | GCST90013405 | 0.04 |
| 6843 | Plasma pregnenetriol sulfate* levels in chronic kidney disease | GCST90265866 | 0.04 |
| 6844 | NRP1 levels | GCST90470085 | 0.04 |
| 6845 | FIS1 levels | GCST90469240 | 0.04 |
| 6846 | Neutrophil count | GCST90002351 | 0.04 |
| 6847 | Conductive hearing loss (PheCode 389.2) | GCST90475912 | 0.04 |
| 6848 | DTI TBSS L3 External capsule R | GCST90384556 | 0.04 |
| 6849 | IDP dMRI TBSS L1 Retrolenticular part of internal capsule L | GCST90004096 | 0.04 |
| 6850 | Other diseases of blood and blood-forming organs, wide | FING00000999 | 0.04 |
| 6851 | F2R/PDGFB ratio | GCST90314733 | 0.04 |
| 6852 | Respiratory disease (confirmatory factor analysis Factor 11) | GCST90309345 | 0.04 |
| 6853 | Cholesterol levels in large HDL | GCST90092844 | 0.04 |
| 6854 | Benign neoplasm of other and unspecified endocrine glands | FING00000159 | 0.04 |
| 6855 | Chronic lung diseases including COPD, Emphysema and Bronchitis | GCST90475272 | 0.04 |
| 6856 | Fasting plasma glucose | GCST90566420 | 0.04 |
| 6857 | FKBP5/MAP4K5 ratio | GCST90314843 | 0.04 |
| 6858 | IDP dMRI ProbtrackX L1 atr r | GCST90004249 | 0.04 |
| 6859 | DTI TBSS MD Posterior corona radiata L | GCST90384599 | 0.04 |
| 6860 | Frequency of friend/family visits | Social support | UKBB00000262 | 0.04 |
| 6861 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T486 | ECGU000486 | 0.04 |
| 6862 | CTSO levels | GCST90468915 | 0.04 |
| 6863 | Acylcarnitine (18:2) levels | GCST90024623 | 0.04 |
| 6864 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T13 | ECGA000013 | 0.04 |
| 6865 | PMVK/PRTFDC1 ratio | GCST90315695 | 0.04 |
| 6866 | aparc-DKTatlas rh volume postcentral | GCST90002913 | 0.04 |
| 6867 | DTI TBSS MD Posterior thalamic radiation L | GCST90384601 | 0.04 |
| 6868 | Phosphatidylcholine-O_40:5_[M+H]1+/Phosphatidylcholine-P_40:4_[M+H]1+ levels | GCST90060423 | 0.04 |
| 6869 | Neutrophil count | GCST90025977 | 0.04 |
| 6870 | PPP1R12A/VEGFC ratio | GCST90315715 | 0.04 |
| 6871 | TNFRSF21 levels | GCST90470912 | 0.04 |
| 6872 | EGLN1/PIK3AP1 ratio | GCST90314619 | 0.04 |
| 6873 | IDP dMRI TBSS MD Posterior limb of internal capsule L | GCST90004046 | 0.04 |
| 6874 | Disorders of plasma-protein metabolism, not elsewhere classified | FING00000455 | 0.04 |
| 6875 | Cardiorespiratory fitness slope | GCST90093319 | 0.04 |
| 6876 | IDP dMRI ProbtrackX FA cgc r | GCST90003930 | 0.04 |
| 6877 | Triacylglycerol_52:2_[M+NH4]1+ levels | GCST90060511 | 0.04 |
| 6878 | T1 FreeSurfer a2009s rh S temporal sup area | GCST90384962 | 0.04 |
| 6879 | HSPG2/PTGDS ratio | GCST90315092 | 0.04 |
| 6880 | Urine 16a-hydroxy DHEA 3-sulfate levels in chronic kidney disease | GCST90264329 | 0.04 |
| 6881 | Length of time at current address | Household | UKBB00000404 | 0.04 |
| 6882 | KDR levels | GCST90243323 | 0.04 |
| 6883 | Cauliflower liking | GCST90094727 | 0.04 |
| 6884 | Phospholipids in medium HDL | GCST90498635 | 0.04 |
| 6885 | Glucose levels (UKB data field 30740) | GCST90468071 | 0.04 |
| 6886 | Congestive heart failure (CHF) NOS (PheCode 428.1) | GCST90475982 | 0.04 |
| 6887 | SRC levels | GCST90470741 | 0.04 |
| 6888 | Myocardial fractal dimension (slice 6) | GCST90000292 | 0.04 |
| 6889 | DIABLO/PDGFB ratio | GCST90314468 | 0.04 |
| 6890 | AK2 levels | GCST90468270 | 0.04 |
| 6891 | DTI TBSS L3 Anterior limb of internal capsule L | GCST90384541 | 0.04 |
| 6892 | CD63/CLEC1B ratio | GCST90313863 | 0.04 |
| 6893 | rfMRI connectivity (ICA100 edge 387) | GCST90005240 | 0.04 |
| 6894 | CELA3A/CTRC ratio | GCST90314012 | 0.04 |
| 6895 | Testosterone levels | GCST90483486 | 0.04 |
| 6896 | Defects in the complement system | FING00000383 | 0.04 |
| 6897 | CCN2/MGLL ratio | GCST90313714 | 0.04 |
| 6898 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T91 | ECGU000091 | 0.04 |
| 6899 | DXO levels | GCST90469055 | 0.04 |
| 6900 | Cholesteryl esters in medium HDL (UKB data field 23569) | GCST90269666 | 0.04 |
| 6901 | CLEC1B/TXNDC5 ratio | GCST90314105 | 0.04 |
| 6902 | Plasma 3-hydroxyhexanoate levels in chronic kidney disease | GCST90264498 | 0.04 |
| 6903 | F-fatty food liking (derived food-liking factor) | GCST90094761 | 0.04 |
| 6904 | DTI autoptx FA ilf r tract | GCST90385127 | 0.04 |
| 6905 | LACTB2 levels | GCST90469726 | 0.04 |
| 6906 | AXIN1/CLIP2 ratio | GCST90313404 | 0.04 |
| 6907 | USP8 levels | GCST90471022 | 0.04 |
| 6908 | Phosphatidylcholine-O_33:3_[M+H]1+/Phosphatidylcholine-P_33:2_[M+H]1+/Phosphatidylethanolamine-O_36:3_[M+H]1+ levels | GCST90060261 | 0.04 |
| 6909 | RAB2B levels | GCST90470406 | 0.04 |
| 6910 | FABP5/PPCDC ratio | GCST90314763 | 0.04 |
| 6911 | DTI TBSS L2 Anterior corona radiata R | GCST90384498 | 0.04 |
| 6912 | NUDT2 levels | GCST90470106 | 0.04 |
| 6913 | MAVS/MYO9B ratio | GCST90315390 | 0.04 |
| 6914 | Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers) | FING00000866 | 0.04 |
| 6915 | wg lh intensity-contrast lateraloccipital | GCST90003802 | 0.04 |
| 6916 | CX3CL1/PODXL2 ratio | GCST90314326 | 0.04 |
| 6917 | Right-hemisphere dorsal attention network to amygdala white-matter structural connectivity | GCST90302811 | 0.04 |
| 6918 | Pizza liking | GCST90094810 | 0.04 |
| 6919 | GP6/TMSB10 ratio | GCST90314975 | 0.04 |
| 6920 | Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levels | GCST90060254 | 0.04 |
| 6921 | Psoriasis vulgaris | GCST90018687 | 0.04 |
| 6922 | SLC9A3R1 levels | GCST90470665 | 0.04 |
| 6923 | TPP1 levels | GCST90470946 | 0.04 |
| 6924 | Chronic ulcer of skin, not elsewhere classified | FING00000300 | 0.04 |
| 6925 | BIN2/FYB1 ratio | GCST90313505 | 0.04 |
| 6926 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T431 | ECGU000431 | 0.04 |
| 6927 | MAP2K6/TBL1X ratio | GCST90315378 | 0.04 |
| 6928 | PDGFA/PRSS27 ratio | GCST90315616 | 0.04 |
| 6929 | TOR1AIP1 levels | GCST90470935 | 0.04 |
| 6930 | CD19 on IgD- CD38- B cell | GCST90001733 | 0.04 |
| 6931 | FYB1/PPP1R12A ratio | GCST90314913 | 0.04 |
| 6932 | Whole body fat mass | Impedance measures | UKBB00000914 | 0.04 |
| 6933 | Exotropia | GCST90572737 | 0.04 |
| 6934 | F-small fish liking (derived food-liking factor) | GCST90094840 | 0.04 |
| 6935 | Total fatty acid levels | GCST90502211 | 0.04 |
| 6936 | RHOC/TBCC ratio | GCST90315775 | 0.04 |
| 6937 | Biological Mother: Coronary Artery / Coronary Heart Disease | GCST90475488 | 0.04 |
| 6938 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T475 | ECGU000475 | 0.04 |
| 6939 | T1 CAT volume R TemporalFusiformCortexposteriordivision | GCST90384075 | 0.04 |
| 6940 | Omega-3 fatty acids to total fatty acids percentage | GCST90502088 | 0.04 |
| 6941 | OCLN levels | GCST90470114 | 0.04 |
| 6942 | Acetate levels | GCST90092803 | 0.04 |
| 6943 | RCC1 levels | GCST90470443 | 0.04 |
| 6944 | Baked/steamed fish liking | GCST90094696 | 0.04 |
| 6945 | Polyunsaturated fatty acid levels | GCST90502133 | 0.04 |
| 6946 | DTI TBSS L3 Superior fronto-occipital fasciculus R | GCST90384566 | 0.04 |
| 6947 | T1 FreeSurfer DK rh cuneus volume | GCST90385761 | 0.04 |
| 6948 | IDP T1 FAST ROIs R cerebellum crus I | GCST90002571 | 0.04 |
| 6949 | SPESP1 levels | GCST90470720 | 0.04 |
| 6950 | CDKN1A/TBL1X ratio | GCST90313977 | 0.04 |
| 6951 | Cholesterol in large HDL (UKB data field 23561) | GCST90269658 | 0.04 |
| 6952 | End-diastolic bi-ventricular shape (principal component 2) | GCST90448481 | 0.04 |
| 6953 | IDP dMRI TBSS L1 Uncinate fasciculus L | GCST90004120 | 0.04 |
| 6954 | IDP T1 FIRST left caudate volume | GCST90002438 | 0.04 |
| 6955 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T436 | ECGU000436 | 0.04 |
| 6956 | GGACT levels | GCST90469333 | 0.04 |
| 6957 | CD8A levels | GCST90468655 | 0.04 |
| 6958 | Colon polyp | GCST90018607 | 0.04 |
| 6959 | Chronic lymphocytic leukemia | GCST90624738 | 0.04 |
| 6960 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502398 | 0.04 |
| 6961 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T487 | ECGU000487 | 0.04 |
| 6962 | Dried fruit intake | Diet | UKBB00000193 | 0.04 |
| 6963 | CDH17/PECAM1 ratio | GCST90313942 | 0.04 |
| 6964 | Cholesteryl esters in large HDL (UKB data field 23562) | GCST90269659 | 0.04 |
| 6965 | CHGB levels | GCST90468742 | 0.04 |
| 6966 | Alzheimer's disease (MTAG) | GCST90449062 | 0.04 |
| 6967 | Rheumatoid arthritis | musculoskeletal | UKBB00000757 | 0.04 |
| 6968 | CLPP/DECR1 ratio | GCST90314137 | 0.04 |
| 6969 | Operation code - caesarean section / caesarian section | Operations | UKBB00000552 | 0.04 |
| 6970 | aparc-a2009s lh volume G-postcentral | GCST90002952 | 0.04 |
| 6971 | BCAM levels | GCST90468425 | 0.04 |
| 6972 | Abnormal findings examination of lungs (PheCode 514) | GCST90476043 | 0.04 |
| 6973 | Concentration of very large HDL particles (UKB data field 23551) | GCST90269648 | 0.04 |
| 6974 | TRAF3 levels | GCST90470957 | 0.04 |
| 6975 | Gout and other crystal arthrop (PheCode 274) | GCST90475731 | 0.04 |
| 6976 | Homeostasis model assessment of beta-cell function | GCST005180 | 0.04 |
| 6977 | CLPS/CTRB1 ratio | GCST90314139 | 0.04 |
| 6978 | DTI autoptx MD str r tract | GCST90385244 | 0.04 |
| 6979 | Snoring | GCST009760 | 0.04 |
| 6980 | MAP3K5 levels | GCST90469854 | 0.04 |
| 6981 | Waist circumference | GCST90103753 | 0.04 |
| 6982 | Biological Father: High blood pressure | GCST90475243 | 0.04 |
| 6983 | aseg lh volume Accumbens-area | GCST90002626 | 0.04 |
| 6984 | IDP dMRI ProbtrackX L1 slf l | GCST90004267 | 0.04 |
| 6985 | F-glutamate liking (derived food-liking factor) | GCST90094772 | 0.04 |
| 6986 | MPO levels | GCST90012031 | 0.04 |
| 6987 | Fluid intelligence score decline (log-difference score) | GCST90565852 | 0.04 |
| 6988 | Docosahexaenoic acid to total fatty acids percentage | GCST90502269 | 0.04 |
| 6989 | Vitiligo | FING00001443 | 0.04 |
| 6990 | LCN2/RETN ratio | GCST90315308 | 0.04 |
| 6991 | IL15 levels | GCST90469556 | 0.04 |
| 6992 | Left ventricular end systole anterospetal wall thickness | GCST90278513 | 0.04 |
| 6993 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T435 | ECGU000435 | 0.04 |
| 6994 | rfMRI connectivity (ICA100 edge 1066) | GCST90005919 | 0.04 |
| 6995 | STK11 levels | GCST90470765 | 0.04 |
| 6996 | F13B levels | GCST90469167 | 0.04 |
| 6997 | CXADR levels | GCST90468922 | 0.04 |
| 6998 | Renal failure | FING00001250 | 0.04 |
| 6999 | Main speciality of consultant (recoded) - Trauma and orthopaedics | Summary Administration | UKBB00000420 | 0.04 |
| 7000 | Cholesteryl ester_18:1_[M+NH4]1+ levels | GCST90060221 | 0.04 |